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C H E M I S T R Y
Rapid approach to complex boronic acids
Constantinos G. Neochoritis1*†, Shabnam Shaabani1*, Maryam Ahmadianmoghaddam1, 
Tryfon Zarganes-Tzitzikas1, Li Gao1, Michaela Novotná1, Tatiana Mitríková1,  
Atilio Reyes Romero1, Marina Ika Irianti1, Ruixue Xu1, Joe Olechno2, Richard Ellson2, 
Victoria Helan3, Michael Kossenjans3, Matthew R. Groves1, Alexander Dömling1‡
The compatibility of free boronic acid building blocks in multicomponent reactions to readily create large libraries 
of diverse and complex small molecules was investigated. Traditionally, boronic acid synthesis is sequential, syn-
thetically demanding, and time-consuming, which leads to high target synthesis times and low coverage of the 
boronic acid chemical space. We have performed the synthesis of large libraries of boronic acid derivatives based 
on multiple chemistries and building blocks using acoustic dispensing technology. The synthesis was performed 
on a nanomole scale with high synthesis success rates. The discovery of a protease inhibitor underscores the use-
fulness of the approach. Our acoustic dispensing–enabled chemistry paves the way to highly accelerated synthesis 
and miniaturized reaction scouting, allowing access to unprecedented boronic acid libraries.
INTRODUCTION
Boron is a unique element of great versatility and individuality, al-
though it seems that nature and evolution have generally bypassed 
it (with the exception of a few natural products, e.g., boromycin) 
(1). Boron plays an exquisite role in synthetic chemistry, with 
boronic acids and their esters of paramount importance to all facets 
of chemical science. Since the introduction of the Pd-catalyzed 
C─C Suzuki-Miyaura couplings (2) that brought boronate esters 
into vogue, the boronic acid moiety has become a very important 
functional group (3). Other highly useful transformations based 
on boronic acids include the Petasis reaction (4), C─N and C─O 
coupling (Chan-Lam coupling) (5, 6), Liebeskind-Srogl coupling 
(7), regioselective deuteration, or sulfonamide formation (8). Boronic 
acids as mild electrophiles are also investigated as reversible covalent 
inhibitors (9, 10), and thousands of different building blocks are 
now commercially available. As a result, boronic acids are increasingly 
being seen in approved drugs, e.g., vaborbactam or bortezomib 
(Fig. 1, A and B) (11, 12).
However, these boron building blocks comprise almost exclusively 
low–molecular weight compounds, as the late-stage functionaliza-
tion of high–molecular weight boronic acids is synthetically demanding 
due to their tedious introduction, modest functional group compati-
bility, regioselectivity issues, and difficulty to parallelize (13, 14). 
Because of the exquisite differential properties of boronic acids, an 
easy access to high–molecular weight elaborated compounds is highly 
desirable. Isocyanide-based multicomponent reactions (IMCRs) 
are well established for functional group compatibility that accounts 
for the immense scaffold diversity that can be generated on the basis 
of some handful primary IMCRs (15, 16). Furthermore, IMCRs 
are useful to access a drug-like chemical space and many marketed 
or experimental drugs (17, 18). Thus, we hypothesized that unprotected 
boronic acids are compatible with the reaction conditions of IMCR 
and can be introduced into complex high–molecular weight com-
pounds of use (19). The use of unprotected boronic acids directly 
could enable a faster access with limited protecting steps to a large 
number of boron-based derivatives. In addition, the screening of these 
compounds (e.g., as covalent inhibitors) could be performed directly 
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Fig. 1. Importance of boronic acids, commonly used synthetic methods for the ─B(OH)2 
introduction, and our proposed building block–centered approach. (A) Marketed drugs 
containing free ─B(OH)2 moieties. (B) Common methods for late-stage introduction of 
the ─B(OH)2 moiety. THF-DMF, tetrahydrofuran-dimethylformamide. (C) Building block 
approach to prepare complex ─B(OH)2 moiety containing molecules in large numbers.
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without further deprotection (Fig. 1C). To test this hypothesis, 
we used an acoustic droplet ejection (ADE)–enabled synthesis plat-
form. In ADE, acoustic waves are applied to eject nanoliter droplets 
from a source plate with building block stock solutions to a destina-
tion plate in which the reaction occurs. While ADE is an established 
dispensing technology in many other scientific areas (e.g., crystal-
lography), it is uncommon in organic synthesis (20). The ADE plat-
form is based on microliter volume chemistry, uses minimal 
resources, is highly automatable, and is useful to screen many build-
ing block combinations in a shorter time frame than other current 
technologies (21).
RESULTS AND DISCUSSIONS
The mechanism-based functional groups required in IMCRs are car-
boxylic acids, amines, oxo components, and isocyanides. We synthesized 
and purchased a number of the first three building block categories. In 
addition, we also synthesized an unknown isocyanide boronic acid in one 
example (Fig. 2). We planned to perform four IMCRs and investigate the 
reaction success rate depending on the reactions, the components, and 
the substitution pattern (e.g., o-, m-, and p-) in combination with 
multiple complementary building blocks chosen in a random fashion.
Optimizing the compatibility of boronic acids for MCR is an inter-
esting synthetic challenge, as the C─B bond is well known to react 
Fig. 2. Boronic acid building blocks used in this study, first synthesis of boronic acid isocyanide, and evaluated reactions. [B], phenyl boronic acid moiety.
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with common MCR starting materials and intermediates under mild 
conditions, e.g., primary, secondary amines, and carbonyl compounds 
(Petasis reaction and others) (22). Moreover, the electrophilic boron 
could unproductively complex to nucleophilic key functional groups 
of MCRs and thereby interrupt the reaction progress (23). Here, we 
used different building blocks (amines, aldehydes, carboxylic acids, 
and isocyanides) with free boronic acids in different positions to 
investigate their compatibility with a number of IMCRs (Fig. 2). 
The stability of the boronic acid moiety in the presence of the iso-
cyanide in one molecule in the absence of such molecules is unknown. 
To this end, we also synthesized the first free boronic acid–containing 
isocyanide. We have extensively investigated the compatibility of mul-
tiple free boronic acid–containing building blocks in multiple IMCRs, 
including the classical Ugi four-component reaction (U-4CR) (24), 
Fig. 3. HT synthesis of boronic acids using the building block approach. (A) Exemplary analytical 384-well plate of the U-4CR scaffold 12 (green, major product formation; 
yellow, product present; blue, product not present). (B) Statistical analysis of the quality of reactions of the different scaffolds. (C) Structures of some unusual reaction 
products from different IMCRs.
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the Ugi tetrazole (UT-4CR) (25), the Gröbcke-Blackburn-Bienaymé 
(GBB-3CR) (26–28), and the Ugi-based macrocycles (scaffolds 12 
to 20; Fig. 3) (29). In addition, we studied the suitability of the cor-
responding boronic acid libraries in a secondary Suzuki cross-coupling 
reaction. We performed the project under extreme resource- and 
time-saving conditions using the ADE-enabled chemistry platform 
in a 384-well format.
We accomplished the synthesis of m-isocyanophenyl boronic 
acid by a classical formylation/dehydration procedure (Fig. 2). Be-
cause of the presumed instability, we immediately used the isocyanide 
after preparation. Using the boronic acid building blocks of Fig. 2, 
we investigated different IMCRs on a nanomole scale using ADE 
technology. The analytics of the four 384-well format plates were 
performed using mass spectrometry (MS) as described previously 
(30), which allowed us to classify the reactions into three groups: 
major (green color), mediocre (yellow color), or no product forma-
tion (blue color). The outcome of the high-throughput (HT) analytics 
for the different reactions is shown in Fig. 3, and a detailed analysis 
of the different building blocks is given in the Supplementary Materials. 
The rapid collection of information facilitated the ability to predict 
outcomes from other possible combinations of reagents. For exam-
ple, it was found that the ortho substituted building blocks 4 and 11 
reacted less efficiently than the corresponding meta or para substi-
tuted in all MCRs (Fig. 2). This can be rationalized by the neighbor 
group effect of boronic acid that might hamper formation or reduce 
reactivity of the key Schiff base. It was also found that boronic acid 
monoesters 5 and 8 were less reactive than their boronic acid coun-
terparts, probably due to the introduction of ring strain around the 
boron center, leading to slightly different electronic properties (31). 
In addition, it was demonstrated that the U-4CR of the three car-
boxyphenyl boronic acids 6 to 8 (heat map shown in Fig. 3A) was 
greatly enhanced when p-formaldehyde was used (>60% of the re-
actions worked; see the Supplementary Materials). Last, it is note-
worthy that formylphenyl boronic acids behave well in the GBB-3CR, 
since more than 50% of the reactions that were performed were suc-
cessful (see the Supplementary Materials). In general, the use of build-
ing blocks without the free ─B(OH)2 moieties was less successful 
than those with boronic acids. This could point to a potential cata-
lytic activity of boronic acids in the GBB-3CR as a Brønsted acid as 
there are many cases of GBB catalysis by Brønsted acids (26–28). 
Detailed analysis of the rich data of the complementary building blocks 
can help to uncover subtle reactivity details.
In our approach, novel substrates could be generated. In the 
GBB-3CR, compound 21 reacted repeatedly well despite the exis-
tence of a hitherto unreported triazolidine-5-thione moiety in this 
context. Another interesting finding is the good reactivity of building 
Fig. 4. Resynthesized complex boronic acid derivatives based on different scaffolds on a millimole scale and corresponding yields.  o
n
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block 22 in the GBB-3CR, in which the formyl group did not react, as 
the additional formyl group could theoretically undergo alternative re-
action pathways such as condensation and addition reactions. Another 
pleasant finding is the good reactivity of tetrahydro--carboline 23 in 
the UT-4CR, which is a pharmacophore in multiple natural pro-
ducts and drugs (e.g., harman and tadalafil). Complex medium-sized 
and macrocycles gave, unexpectedly, very good results (e.g., medium- 
sized cycle 24). Last, we observed functional group tolerance and 
selectivity. In the case of U-4CR 25, we used a diamine, which reacted 
only once, leaving a primary amine behind. The HT synthesis ap-
proach displayed here is a treasure trove to uncover interesting unknown 
reactivities that deserve further investigation and detailed analysis 
in a narrower compound series.
The scalability from the nanomole to the millimole scale is often 
problematic. Therefore, we resynthesized multiple examples of each 
compound series (compounds 12 to 20) on a millimole scale (including 
Fig. 5. HT Suzuki reaction of boronic acids using the building block approach. (A) Statistical analysis of the aryl halides that were used in the HT screening (green, major 
peak in MS; yellow, product present; blue, product not present). (B) A one-pot resynthesized compound 28 on a millimole scale and isolated yield. DME, dimethoxyethane.
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full characterization) to verify our ADE results (Fig. 4) and to iden-
tify any potential bottlenecks into transferring synthesis from ADE 
technology to classical approaches.
Boronic acids are exceedingly useful functional groups and the 
starting materials for many reactions. To underscore the usefulness 
of our building block approach, we investigated multiple boronic 
acid building blocks in a subsequent Suzuki C─C coupling. We per-
formed reaction scouting in 384-well polypropylene plates using ADE; 
after the transfer of starting materials, we incubated the plates at 
50°C overnight. Again, we resynthesized an example on a millimole 
scale in a one-pot fashion (compound 28; Fig. 5).
To further underscore the usefulness of our fast, convergent, 
and highly diverse access of boronic acid libraries, we screened for 
inhibition of the biological target MptpB, a virulence factor from 
Mycobacterium tuberculosis (32). MptpB belongs to the notoriously 
undruggable target class of phosphatases that, despite their overar-
ching relevance in medicine, suffer from having no approved drug 
(33). This is generally attributed to the highly positively charged ac-
tive site of phosphatases requiring negatively charged inhibitors 
that cannot overcome membrane penetration issues (34). Looking 
for a potential covalent interaction between the active-site nucleophiles 
Cys160, Thr223, and Ser57 of MptpB and an electrophilic boronic 
acid, we screened the library in a colorimetric enzyme assay (see the 
Supplementary Materials). In this assay, we found several hits, the 
most potent one 18a (Fig. 6). The exact binding mode of 18a is un-
clear due to the large number of reactive Ser, Cys, and Thr on the 
surface and in the active site of MptpB (the Supplementary Materials). 
Modeling studies of 18a in MptpB with Cys160, Ser57, and Thr223 were 
performed and suggest a covalent adduct to a tetrahedral boron 
(Fig. 6C and see the Supplementary Materials).
Classical access to boronic acids by late-stage functionalization 
of complex molecules suffers from a lack in functional group com-
patibility and regioselectivity and often requires harsh conditions 
that are incompatible with molecule stability (35–38). Here, we in-
troduced the concept of boronic acid building blocks combined with 
the diversity of MCRs as a valid approach for the synthesis of large 
and unprecedented libraries of boronic acids. Our studies go much 
beyond a singleton report on the use of a few free boronic acids in 
the Ugi reaction as we also investigated the GBB-3CR, UT-4CR, and 
several different IMCR variations more in an unprecedented breadth 
of building block combinations (35, 36). In other reports, isocyanide- 
bearing boronic acids are only known in their protected ester form 
that would need another, often harsh, deprotecting step to yield boronic 
acids suitable for screening (39, 40). Here, we found that IMCR gen-
erally runs under such mild conditions that free boronic acids are 
widely tolerated. We systematically investigated 10 different boronic 
acid building blocks with complementary functional groups (primary 
amine, aldehyde, carboxylic acid, and isocyanide) and combined them 
with 353 different reactants in four IMCRs. More than 1300 different 
combinations were investigated in a nanomole miniaturized and 
automated fashion using ADE technology. HT analytics using MS 
revealed that the different reactions worked better than satisfactorily 
in 714 cases (458 giving the main product and 256 cases a satisfactory 
yield). Many subtle reactivities were uncovered, which in a classical 
millimole scale reaction, evaluation approach could never been elu-
cidated in a reasonable time frame. Upscaling of a substantial number of 
diverse products revealed the synthetic usefulness of the approach. Last, we 
probed our library to uncover previously unknown boronic acid–based 
covalent inhibitors for a notoriously undruggable phosphatase tar-
get, identifying a micromolar inhibitor. We believe our described 
building block approach will widen the accessibility of the boronic 
acid chemical space markedly for applications in synthesis, chemical 
biology, and drug discovery. This is also true in light of the recently 
found catalytic enantioselective Ugi reaction (41).
Fig. 6. Covalent inhibition of tuberculosis target MptpB. (A) Screening of the boronic acid library by a colorimetric enzyme assay. (B) Median inhibitory concentration 
(IC50) of compound 18a. (C and D) Modeling of compound 18a into MptpB [Protein Data Bank (PDB) ID: 2OZ5], where it forms a covalent adduct with active-site cysteine. 
Van der Waals interactions, hydrogen bonding, and cation- interactions are indicated by yellow, red, and blue dotted lines, respectively.
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MATERIALS AND METHODS
All the reagents and solvents were purchased from Sigma-Aldrich, 
AK Scientific, Fluorochem, abcr GmbH, and Acros and were used 
without further purification. All isocyanides were prepared in-house 
(see the Supplementary Materials). All microwave irradiation reac-
tions were carried out in a Biotage Initiator microwave synthesizer. 
Thin-layer chromatography was performed on Millipore precoated 
silica gel plates (thickness, 0.20 mm; particle size, 25 m). Nuclear 
magnetic resonance spectra were recorded on Bruker Avance 500 
spectrometers [1H NMR (nuclear magnetic resonance; 500 MHz), 
13C NMR (126 MHz)]. Chemical shifts for 1H NMR were reported 
as  values, and coupling constants were in hertz. The following ab-
breviations were used for spin multiplicity: s, singlet; br s, broad singlet; 
d, doublet; t, triplet; q, quartet; quin, quintet; dd, double of doublets; 
ddd, double doublet of doublets; and m, multiplet. Chemical shifts 
for 13C NMR were reported in parts per million relative to the sol-
vent peak. Flash chromatography was performed on a Reveleris X2 
flash chromatography system, using Grace Reveleris Silica flash car-
tridges (12 g). Mass spectra were measured on a Waters Investigator 
Supercritical Fluid Chromatograph with a 3100 MS detector (ESI) 
using a solvent system of methanol and CO2 on a Viridis silica gel 
column (4.6 × 250 mm, 5-m particle size) or Viridis 2-ethyl pyridine 
column (4.6 × 250 mm, 5-m particle size). High-resolution mass 
spectra were recorded using an LTQ Orbitrap XL (Thermo Fisher 
Scientific) at a resolution of 60,000 at m/z 400. The Echo 555 liquid 
handler (Labcyte) was used to transfer nanoliter droplets of start-
ing materials from the 384-well source plate to the 384-well destina-
tion plate.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/7/eaaw4607/DC1
Supplementary Materials and Methods
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